Skip to content

Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric Comparative Study

Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric Comparative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05271721
Enrollment
90
Registered
2022-03-09
Start date
2022-03-01
Completion date
2023-05-01
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

Transforaminal injection of chronic radicular lower limb injection by either dexmedetomdine or magnesuim sulfate

Interventions

DRUGepidural transforaminal injection of magnesuim sulfate

transforaminal fluroscopic guided

DRUGepidural transforaminal injection of dexmedtemodine

transforaminal fluroscopic guided

DRUGtransforaminal epidural injection of dexamethasone

transforaminal fluroscopic guided

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age group. 25-75ys old * Both sex. * Lumber disc protrusion at one or two segments on MRI. * Chronic lumbar radiculer pain for more than 6 weeks refractory to * medical treatment for at least 4 weeks. . * Positve leg rising test at 30-70 degrees.

Exclusion criteria

* Diabetic candidates ( type Ior II). * Patient refusal. * MRI with disc sequestration. * Neurological examination revealed foot drop, neuropathic ulcers * Myelopathic or scoliotic patients, . * Coagulopathic patients ( cirrhotic patients, on anti-coagulation )

Design outcomes

Primary

MeasureTime frameDescription
pain scoreup to 6 months post-injectionvisual analogue pain score. pain value of (0 cm) equals no pain , and value of (10 cm) equals worst pain

Secondary

MeasureTime frameDescription
functional disabilityup to 6 months post injectionModified Oswestry Disability Questionnaire....0% to 20%: minimal disability:....21%-40%: moderate disability: 41%-60%: severe disability...61%-80%: crippled
acute complications6 hours post-injectionnumber of patients developed epidural hematoma by magnetic resonance imaging

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026